| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,504.65
|
|
Change (%)
|
-46.45 (-1.82%)
|
|
Best Buy (RS)
|
2499.75(x12)
|
|
Best Sell (RS)
|
2504.7(x18)
|
|
Today's Range (RS)
|
2,494.90
-
2,599.80
|
|
52-Week Range (RS)
|
2,088.00
-
3,217.10
|
|
Beta (1 Year)
|
0.49
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| GlaxoSmithKline Pharmaceuticals to table results |
| Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter |
| GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr |
| GlaxoSmithKline Pharmaceuticals to hold AGM |
| Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend |
| Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter |
| GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr |
| GlaxoSmithKline Pharmaceuticals to announce Quarterly Result |
| Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology |
| Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter |
|
|
|
| Incoporation Year : 1924 |
| Chairman : Renu S. Karnad |
| Ownership Group : MNC Asc-Glaxo |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030 |
Phone:91-022-24959595
Fax:91-022-24959494 |
| E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com |
| URL : http://www.gsk-india.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
15-Jul-2026 |
2485.65 |
2.63 |
| 1Month |
22-Jun-2026 |
2365.55 |
7.84 |
| 3Month |
22-Apr-2026 |
2462.75 |
3.59 |
| 6Month |
22-Jan-2026 |
2379.85 |
7.20 |
| 1Year |
22-Jul-2025 |
3098.40 |
-17.66 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Midcap Fund |
1.22 |
294.04 |
| Kotak Large & Midcap Fund |
0.86 |
269.53 |
| Nippon India Pharma Fund |
2.47 |
223.77 |
| Nippon India Growth Mid Cap Fund |
0.28 |
136.97 |
| SBI Dividend Yield Fund |
1.30 |
110.26 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
28,750.00 |
-0.51 |
35,280.00 |
25,164.00 |
61,409.53 |
| Pfizer Ltd |
4,658.00 |
0.35 |
5,878.55 |
4,361.00 |
21,235.87 |
| Astrazeneca Pharma India Ltd |
7,878.05 |
-1.93 |
9,850.00 |
7,630.00 |
20,082.63 |
| Procter & Gamble Health Ltd |
6,710.00 |
-0.12 |
6,955.00 |
4,699.70 |
11,151.80 |
| Sanofi Consumer Healthcare India Ltd |
4,644.15 |
0.71 |
5,493.10 |
3,950.50 |
10,620.11 |
|
|
|
|